Search research articles
Contact Us
Filters
Showing results (261-270 of 268) with videos related to
Page
of 27
Sort By:
You have reached the last page of results.
This site can display upto 268 results.
The New England Journal of Medicine
|
May 22, 1986
Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications
P W Gold, D L Loriaux, A Roy, et al.
The American Journal of Psychiatry
|
December 1, 1996
Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients
D Pickar, T P Su, D R Weinberger, et al.
Psychopharmacology
|
January 1, 1981
Naloxone effects on beta-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers
D Naber, D Pickar, G C Davis, et al.
International Journal of Psychiatry in Clinical Practice
|
June 18, 2014
Treatment of schizophrenic disorders: Algorithms for acute pharmacotherapy
A C Altamura, C Barnas, I Bitter, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 18, 1997
Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method
A Breier, T P Su, R Saunders, et al.
The American Journal of Psychiatry
|
January 1, 1997
Cerebrospinal fluid monoamine metabolites in childhood-onset schizophrenia
L K Jacobsen, J A Frazier, A K Malhotra, et al.
The American Journal of Psychiatry
|
February 1, 1981
Behavioral and biological effects of acute beta-endorphin injection in schizophrenic and depressed patients
D Pickar, G C Davis, S C Schulz, et al.
Archives of General Psychiatry
|
March 1, 1982
Short-term naloxone administration in schizophrenic and manic patients. A World Health Organization Collaborative Study
D Pickar, F Vartanian, W E Bunney, et al.
Page
of 27
Search research articles
Search
Showing results (261-270 of 268) with videos related to
Sort By:
Page
of 27
You have reached the last page of results.
This site can display upto 268 results.
The New England Journal of Medicine
|
May 22, 1986
Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications
P W Gold, D L Loriaux, A Roy, et al.
The American Journal of Psychiatry
|
December 1, 1996
Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients
D Pickar, T P Su, D R Weinberger, et al.
Psychopharmacology
|
January 1, 1981
Naloxone effects on beta-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers
D Naber, D Pickar, G C Davis, et al.
International Journal of Psychiatry in Clinical Practice
|
June 18, 2014
Treatment of schizophrenic disorders: Algorithms for acute pharmacotherapy
A C Altamura, C Barnas, I Bitter, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 18, 1997
Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method
A Breier, T P Su, R Saunders, et al.
The American Journal of Psychiatry
|
January 1, 1997
Cerebrospinal fluid monoamine metabolites in childhood-onset schizophrenia
L K Jacobsen, J A Frazier, A K Malhotra, et al.
The American Journal of Psychiatry
|
February 1, 1981
Behavioral and biological effects of acute beta-endorphin injection in schizophrenic and depressed patients
D Pickar, G C Davis, S C Schulz, et al.
Archives of General Psychiatry
|
March 1, 1982
Short-term naloxone administration in schizophrenic and manic patients. A World Health Organization Collaborative Study
D Pickar, F Vartanian, W E Bunney, et al.
Page
of 27